Individuals Coming Off Weight-Loss Jabs Regain Weight Four Times Faster Than Dieters

A recent study suggests that people who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight far faster than those who stop traditional diet and exercise regimens.

Findings released in a leading medical journal demonstrates that while overweight people often shed substantial amounts of their total mass while on the medication, the weight returns at an average rate of 0.8 kg per month after stopping.

"Individuals buying such drugs must be aware of the danger of rapid weight regain when the medication concludes," stated lead investigator Dr. Susan Jebb.

This pace of regain means a return to starting weight within about a year and a half.

Weighing Approaches

The analysis, which examined dozens of trials involving over 9,000 of participants, compared the results of these new drugs with conventional dieting.

Scientists emphasize that people who shed pounds through diet and exercise generally have a less rapid creep back—perhaps 0.1 kg a month—post-intervention.

The Reason for the Fast Rebound

Doctors propose the way of the injections explains the amplified regain.

The injections mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Artificially providing GLP-1 concentrations several times higher than the body's typical production might result in the body to produce less of its own natural hormone, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Stopping of this GLP-1 'fix' means appetite is no longer kept in check, making excessive eating far more likely."

A Chronic Condition?

The NHS recommend the injections for people with obesity-related health risks, accompanied by prescribed lifestyle changes.

Professionals contend that, considering the likelihood of relapse, the treatment is often ongoing.

This view is supported by drug manufacturers, who state that the findings "underscore the long-term nature of excess weight," comparing it to managing conditions like high blood pressure.

User Testimonies

Individuals who have discontinued the medication describe a intense return of hunger.

"It felt as if a switch flipping and I was suddenly extremely hungry," said an individual.

This difficulty is worsened if individuals have not adopted lasting lifestyle or habit changes during therapy.

Significant Use

Recent estimates indicate that millions of people in the UK have tried weight-loss jabs in the past year, with desire remaining high.

• Adoption is higher among women than males.
• The middle-aged demographic shows the greatest level of interest.
• Many obtain the drugs through private healthcare rather than the NHS.

Finally, researchers emphasize that while the jabs are powerful agents for shedding pounds, they are not a magic cure and long-term success hinges on integrated behavioural support.